PRICE T ROWE ASSOCIATES INC /MD/
Position in KROS — Keros Therapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in KROS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$600,494
+$94,023 QoQ
Shares Held
56,121
+22.3% QoQ
Ownership
0.283%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 131 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KROS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. KROS ranks #196 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in KROS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $600,494 | 56,121 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $506,471 | 45,876 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $604,671 | 29,699 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $790,699 | 49,981 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $646,340 | 48,415 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $440,483 | 43,227 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $14,400,661 | 909,707 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $87,947,304 | 1,514,505 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $54,287,487 | 1,187,910 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $80,664,964 | 1,218,504 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $41,418,030 | 1,041,701 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $40,399,355 | 1,267,232 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $51,043,104 | 1,270,361 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $49,212,432 | 1,152,516 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $29,829,495 | 621,189 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $366,042 | 9,730 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $244,981 | 4,505 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $384,235 | 6,567 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||